These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 26229021)
21. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia. Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015 [TBL] [Abstract][Full Text] [Related]
22. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Alos L; Moyano S; Nadal A; Alobid I; Blanch JL; Ayala E; Lloveras B; Quint W; Cardesa A; Ordi J Cancer; 2009 Jun; 115(12):2701-9. PubMed ID: 19365846 [TBL] [Abstract][Full Text] [Related]
23. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284 [TBL] [Abstract][Full Text] [Related]
24. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of high-risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas. Kakkar A; Satapathy S; Sikka K; Tanwar P; Deo S; Jain D Virchows Arch; 2023 Sep; 483(3):381-392. PubMed ID: 37452847 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma. Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907 [TBL] [Abstract][Full Text] [Related]
27. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381 [TBL] [Abstract][Full Text] [Related]
28. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
29. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467 [TBL] [Abstract][Full Text] [Related]
30. The role of human papillomavirus in p16-positive oral cancers. Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas in northern Spain. Rodrigo JP; Hermsen MA; Fresno MF; Brakenhoff RH; García-Velasco F; Snijders PJ; Heideman DA; García-Pedrero JM Cancer Epidemiol; 2015 Feb; 39(1):37-41. PubMed ID: 25468644 [TBL] [Abstract][Full Text] [Related]
32. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation. Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614 [TBL] [Abstract][Full Text] [Related]
33. Quantitative polymerase chain reaction-based detection of HPV 16 E6 and E7 DNA in oral squamous cell carcinoma. Thammaiah S; Venkobarao MC; Sathyavanthan H; Mirnalini AS J Oral Pathol Med; 2018 Oct; 47(9):873-879. PubMed ID: 30059164 [TBL] [Abstract][Full Text] [Related]
34. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Wilczynski SP; Lin BT; Xie Y; Paz IB Am J Pathol; 1998 Jan; 152(1):145-56. PubMed ID: 9422532 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of p16 Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245 [TBL] [Abstract][Full Text] [Related]
36. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631 [TBL] [Abstract][Full Text] [Related]
38. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
39. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126 [TBL] [Abstract][Full Text] [Related]
40. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M; Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]